EXAS logo

Exact Sciences Corp.

EXAS

$57.51

- $7.26 (-11.21%) This month

Closed: 23 Feb 2024 21:00 US/Eastern

Key details

CEO

Kevin Conroy

Employees

5,120

Headquarters

Madison, US

Sector

Health Care and Social Assistance

Industry

Diagnostic Imaging Centers

About Exact Sciences Corp.

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG